Higher infused CD34+ cell dose and overall survival in patients undergoing in vivo T-cell depleted, but not t-cell repleted, allogeneic peripheral blood hematopoietic cell transplantationAbraham S. Kanate, Mehdi Hamadani, Pamela Bunner et al.|Hematology/Oncology and Stem Cell Therapy|2011Cited by 10
93: Outcome with a thiotepa containing regimen and autologous HSCT in patients with NHLAaron Cumpston, Solveig G. Ericson, Deirdre Bulian et al.|Transplantation and Cellular Therapy|2007Cited by 1
High Rates of Non-Relapse Mortality and Graft-Versus-Host Disease in Patient Undergoing Allogeneic Stem Cell Transplantation (ASCT) Following Non-Myeloablative (NMA) Conditioning With TLI/ATGAbraham S. Kanate, Mehdi Hamadani, Michael Craig et al.|Transplantation and Cellular Therapy|2011Cited by 0